India’s drug regulator warns on Abbott’s bioresorbable stentsPost published:August 9, 2017Post category:Industry NewsThe Drug Controller General of India’s (DCGI) warning pertains to bioresorbable stents used in blood vessels that are 2.5mm or narrower Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostDilip Shanghvi’s oil firm may buy GSPC’s Hazira field Next PostBoeing eyes India tie-ups for drones, digital technology You Might Also Like Siemens announces plans to develop IPCs for medical market March 1, 2018 PI introduces EtherCat compatible version of its E-727 digital piezo controller family. May 1, 2019 FDT Group announces Executive Committee approval of FDT IIoT Server (FITS) specification for release to the FDT membership June 25, 2019
FDT Group announces Executive Committee approval of FDT IIoT Server (FITS) specification for release to the FDT membership June 25, 2019